Moderna Expects 2025 Revenue Of $2.5B-$3.5B Vs. Consensus Of $3.74B, For 2026-2028 The Company Expects A Compounded Annual Growth Rate Of More Than 25% Or More, Driven By New Product Launches
Portfolio Pulse from Benzinga Newsdesk
Moderna projects its 2025 revenue to be between $2.5 billion and $3.5 billion, which is below the consensus estimate of $3.74 billion. However, the company anticipates a compounded annual growth rate of over 25% from 2026 to 2028, driven by new product launches.
September 12, 2024 | 10:11 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Moderna's 2025 revenue forecast of $2.5B-$3.5B is below the consensus of $3.74B, potentially impacting short-term stock performance. However, the company expects strong growth from 2026-2028 with a CAGR of over 25%, driven by new product launches.
The lower-than-expected revenue forecast for 2025 could lead to a negative short-term impact on Moderna's stock price as it falls below market expectations. However, the long-term growth potential with a CAGR of over 25% from 2026-2028 due to new product launches may mitigate this impact over time.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100